Clinical Trial Update: Evaluation of a Cognitive Adaptive E-treatment in Schizophrenia-diagnosed Adults [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating a cognitive adaptive e-treatment for adults with schizophrenia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Cognitive Adaptive E-treatment

Snippet

Sponsor: Posit Science Corporation | Conditions: Schizophrenia | Phase 2 | Status: COMPLETED